Zai Lab (ZLAB) Partner Novocure (NVCR) Announces METIS Phase 3 Clinical Trial Met Primary Endpoint

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/29/2026

1. V
2. KLAC
3. PYPL
4. BE
5. SWKS
6. F
7. STX
8. CSGP
9. VRNS
10. NXPI

Go back to Zai Lab (ZLAB) Partner Novocure (NVCR) Announces METIS Phase 3 Clinical Trial Met Primary Endpoint
(NASDAQ: NVCR) Delayed: 15.78 -0.53 (3.25%)
Previous Close $16.31    52 Week High $28.95 
Open $16.06    52 Week Low $5.95 
Day High $16.39    P/E N/A 
Day Low $15.75    EPS $0.00 
Volume 227,897       

(NASDAQ: ZLAB) Delayed: 18.23 -0.39 (2.09%)
Previous Close $18.62    52 Week High $ 
Open $18.33    52 Week Low $ 
Day High $18.36    P/E N/A 
Day Low $18.10    EPS $ 
Volume 135,689